Cetirizine-d8 (hydrochloride) – 500 µg

Brand:
Cayman
CAS:
2070015-04-0
Storage:
-20
UN-No:
Non-Hazardous - /

Cetirizine-d8 (hydrochloride) is intended for use as an internal standard for the quantification of cetirizine (Item No. 19686), (R)-cetirizine (Item No. 23992), and (S)-cetirizine by GC- or LC-MS. Cetirizine is a bioactive carboxylated metabolite of hydroxyzine (Item No. 24039) that acts as a selective histamine H1 receptor antagonist (Ki = 10 nM).{15199,31604} As a second generation antihistamine, it is non-sedating due to low lipophilicity, which prevents blood-brain barrier transit.{31603} Cetirizine is a racemic mixture composed of equal amounts of two enantiomers, (R)-cetirizine (Item No. 23992) and (S)-cetirizine, with pharmacological activity residing primarily in the (R) isomer.{31604} Cetirizine inhibits eosinophil chemotaxis and leukotriene B4 (LTB4; Item No. 20110) release independent from H1 antagonism.{31605} It inhibits aerosol histamine-induced bronchospasm in guinea pigs (ED50 = 100 μg/kg, p.o.).{47108} Formulations containing cetirizine have been used in the treatment of allergic rhinitis and chronic urticaria.  

 

Available on backorder

SKU: 26445 - 500 µg Category:

Description

An internal standard for the quantification of cetirizine, (R)-cetirizine, and (S)-cetirizine by GC- or LC-MS


Formal name: 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl-d8]ethoxy]-acetic acid, dihydrochloride

Synonyms: 

Molecular weight: 469.9

CAS: 2070015-04-0

Purity: ≥99% deuterated forms (d1-d8)

Formulation: A solid


Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Isotopically Labeled Standards|Deuterium||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Immunology & Inflammation|Allergy||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Leukotrienes||Research Area|Immunology & Inflammation|Innate Immunity